IM Cannabis

IMCC

Drug Manufacturers - Specialty & Generic · Healthcare

Exchange

NASDAQ Capital Market

Winston Score

Winston is worried

Weak fundamentals across most pillars.

Data as of Aug 23, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Weak

Growth

Weak

Cash Flow

Weak

Stability

Data not available

Valuation

Data not available

Track this stock — start free trial

Winston Score History

The full picture

IM Cannabis Corp. is a cannabis company that grows, processes, and sells medical marijuana products. It serves patients and medical customers in Israel and Germany, two of the more established legal medical cannabis markets in Europe and the Middle East. The company sources cannabis from licensed producers and distributes it under its own brands.

IM Cannabis makes money by selling medical cannabis flower, oils, and related products to pharmacies, clinics, and distributors. It operates primarily in Israel, where it has a stronger foothold, and has been expanding into Germany, which is one of the largest potential medical cannabis markets in Europe. The company is small, with a market cap near zero, and runs on thin margins with operating income barely breaking even. The main growth driver is Germany's expanding medical cannabis regulations, but the main risk is the company's limited financial resources and intense competition from larger, better-funded cannabis producers.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-38.6% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-406.3% YoY

YoY Growth Rate

Earnings declining

Insider Activity

69.1%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~8 months

$4M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

IM Cannabis has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

19.8%

Thin — 19.8% gross margin

Profit after running costs

Operating Margin

-27.5%

Losing money on operations — -27.5%

Return on the money invested

ROCE

-25.9%

Weak — -25.9% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

-20.7%

Shrinking sales (-20.7% YoY)

Profit growth

EPS YoY

N/A

Data not available

How steady the profit is

EPS Consistency

4/8 quarters

Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

-5.7%

Burning cash (-5.7%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/A

no trend

Data not available

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial